Levothyroxine Sodium Tablet
Product Images NDC 51655-604

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 604 52 Master Bottle Label Approval Rev B 04 21)

Label (51655 604 52 Master Bottle Label Approval   Rev B 04 21)
This is a medication called Levothyroxine Sodium Tablets, USP with an NDC (National Drug Code) number of 51655-604-52. Each tablet contains 112mcg (0.112mg) of Levothyroxine sodium. The medication is only available with a prescription and comes in a bottle of 30 tablets. The dosage is to be determined by the package insert. The medication should be stored at 20° - 25°C (68°-77°F) in the original container and kept away from children. The container should be tightly closed and protected from light and moisture. The LCN# is 00 and REV B 04721. The medication was repackaged by Northwind Pharmaceuticals, LOT 0000000000, located in Indianapolis, IN 46203. The S/N# is 000000000000000 and the EXP date is 00/00/0000.*
FDA Label Image

Levothyroxine Sodium Structural Formula (Image 13)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.